UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-08-11 | -2.71 | -2.71 |
| Q1 2022 | 2022-05-12 | 0.00 | 0.00 |
| Q4 2021 | 2022-03-30 | -0.20 | -0.20 |
| Q3 2021 | 2021-11-02 | -0.18 | -0.18 |
| Q2 2021 | 2021-07-26 | -0.20 | -0.20 |
| Q1 2021 | 2021-05-04 | -0.20 | -0.20 |
| Q4 2020 | 2021-03-01 | -0.20 | -0.20 |
| Q3 2020 | 2020-11-12 | -0.18 | 0.00 |
| Q2 2020 | 2020-08-11 | -0.12 | -0.12 |
| 2016-07-08 | Reiterated Rating | Noble Financial | Buy | $15.00 |
| 2016-06-17 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-06-17 | Reiterated Rating | FBR & Co | Buy | |
| 2016-06-02 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-31 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-05-10 | Reiterated Rating | Cantor Fitzgerald | Buy | $18.00 |
| 2016-05-10 | Reiterated Rating | FBR & Co. | Buy | $17.00 |
| 2016-03-10 | Reiterated Rating | Cantor Fitzgerald | Buy | $18.00 |
| 2016-02-02 | Reiterated Rating | RBC Capital | Outperform | $13.00 to $15.00 |
| 2016-02-02 | Reiterated Rating | Royal Bank Of Canada | Outperform | $13.00 to $15.00 |
| 2016-01-28 | Reiterated Rating | FBR & Co. | Outperform | $17.00 |
| 2016-01-08 | Initiated Coverage | Cantor Fitzgerald | Buy | $18.00 |
| 2015-12-30 | Initiated Coverage | Noble Financial | Buy to Buy | $16.00 |
| 2015-11-10 | Reiterated Rating | William Blair | Buy | $18.00 |
| 2015-10-20 | Reiterated Rating | William Blair | Buy | $18.00 |
| 2015-05-14 | Reiterated Rating | Cantor Fitzgerald | Buy | $20.00 |
| 2015-04-02 | Initiated Coverage | FBR & Co. | Outperform | $17.00 |
| 2015-03-27 | Reiterated Rating | Cantor Fitzgerald | Buy | $20.00 |
| 2014-12-30 | Initiated Coverage | Sterne Agee CRT | Buy | |
| 2014-12-18 | Initiated Coverage | Sterne Agee CRT | Buy | |
| 2014-06-17 | Initiated Coverage | William Blair | Outperform | |
| 2014-06-17 | Initiated Coverage | Cantor Fitzgerald | Buy | $17.00 |
| 2014-06-17 | Initiated Coverage | Janney Montgomery Scott | Buy | $18.00 |
| 2014-06-17 | Initiated Coverage | RBC Capital | Outperform | $12.00 |
| 2016-07-08 | Reiterated Rating | Noble Financial | Buy | $15.00 |
| 2016-06-17 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-06-17 | Reiterated Rating | FBR & Co | Buy | |
| 2016-06-02 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-31 | Reiterated Rating | Cantor Fitzgerald | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AGRX 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Moorin Jay | 27.23% (5062363) | AGRX / EGRX / |
| INVESTOR AB | 18.88% (3509949) | AGRX / |
| Care Capital III LLC | 16.19% (3010189) | AGRX / BOTA / NERV / NRX / |
| AISLING CAPITAL III LP | 13.90% (2583797) | AGRX / DRTX / LOXO / TRXC / TTOO / VSAR / |
| SCHIFF ANDREW N | 11.68% (2171831) | AGRX / ZLTQ / |
| ALTOMARI ALFRED Chief Executive Officer | 0.96% (178254) | AGRX / INSM / REPH / |
| Selman Renee Chief Commercial Officer | 0.39% (71628) | AGRX / |
| Coiante Scott M Chief Financial Officer | 0.08% (14686) | AGRX / |
| Garner Elizabeth Sr. VP & Chief Medical Officer | 0.06% (11735) | AGRX / |
| Gilmore Geoffrey General Counsel | 0.06% (11732) | AGRX / |
| Shetty Ajit | 0.04% (7000) | AGRX / |
UM